Levobupivacaine Altan Pharma

Levobupivacaine, the active ingredient in Levobupivacaine Altan Pharma, is a local anesthetic (amide type) presented as a sterile solution for epidural, infiltration, and intrathecal use. It provides regional anesthesia for surgical procedures and pain management in adult patients. It is indicated for use in adult patients undergoing surgery, obstetric procedures, and postoperative pain control.

GNH USA supplies Levobupivacaine Altan Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality and regulatory compliance.

Levobupivacaine is employed in regional anesthesia to block nerve conduction during surgical and obstetric procedures.

- Surgical anesthesia: provides long‑lasting numbness for operative sites - Obstetric analgesia: enables epidural pain relief during labor - Post‑operative pain control: allows infiltration for postoperative analgesia - Dental procedures: facilitates local infiltration anesthesia for oral surgery - Peripheral nerve block: offers anesthesia for limb surgeries

Common Side Effects: - Hypotension: transient drop in blood pressure - Bradycardia: slowed heart rate - Nausea: mild to moderate nausea - Dizziness: occasional light‑headedness

Serious or Rare Side Effects: - Cardiac arrest: rare but life‑threatening arrhythmia - Seizures: central nervous system toxicity - Methemoglobinemia: rare blood disorder causing reduced oxygen delivery - Allergic reaction: anaphylaxis or severe hypersensitivity

Levobupivacaine should be used with careful clinical assessment and monitoring. - Allergy assessment: verify no known hypersensitivity to amide‑type local anesthetics - Cardiovascular monitoring: observe heart rate and blood pressure during administration - Dose calculation: adjust for patient weight and comorbidities - Concurrent CNS depressants: use caution with other agents that may lower seizure threshold - Pregnancy and lactation: consider risk‑benefit, use only if clearly needed - Store at ambient temperature: keep in original container, protect from light and moisture

Levobupivacaine may interact with several drug classes; monitoring is advised.

Major Interactions (Avoid): - Class I anti‑arrhythmics (e.g., quinidine): may increase cardiotoxicity - Beta‑blockers: can potentiate bradycardia - Other local anesthetics: additive toxicity risk

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): may raise plasma levels - Diuretics: may affect plasma protein binding - Magnesium sulfate: may enhance neuromuscular blockade